The Patients and Survivors Program investigates methods of measuring and improving quality of life and quality of cancer care. Its prevention and control research targets are patients receiving treatment for cancer and post-treatment cancer survivors. Research includes behavioral intervention research, assessment of quality of life and other health care outcomes, nutritional intervention research and symptom control research. Policy relevant research related to quality of care is also included.
- Reduce avoidable morbidity and mortality among patients with cancer and long-term survivors of cancer
- Understand and improve quality of life outcomes along the developmental phases of the life span continuum (e.g., infants, children, young adult survivors, adult cancer patients and survivors and elderly cancer patients and survivors), including late medical and psychosocial effects
- Develop and improve methods of measuring and evaluating the quality of cancer care
Meetings and Events
- Monthly research conferences and brown bag seminars in collaboration with the School of Public Health
- Postdoctoral fellows’ journal club
- Research-in-progress meetings with fellows
- Monthly tea for program area members and staff with UCLA Center for Cancer Prevention and Control Research
- Regular meetings on psychoneuroimmunology and cancer for investigators to present their work in progress
- Focused retreats on interdisciplinary and translational topics with other cancer center programs
Patricia A. Ganz, M.D., director of the Patient and Survivors Program, is a board-certified medical oncologist who has been conducting psychosocial and quality of life research with cancer patients and survivors since the early 1980s. Ganz holds professorial appointments in the School of Public Health (Health Policy & Management) and the School of Medicine (Medicine/Hematology-Oncology). Ganz is a pioneer in the assessment of quality of life in cancer patients, and is active in clinical trials research with the NRG Oncology, where she co-chairs the Patient Centered Outcomes Research committee. She has focused much of her clinical and research efforts in the areas of breast cancer and its prevention. She also directs the UCLA Clinical Cancer Genetic Evaluation Program. Her other major areas of research include cancer survivorship and late effects of cancer treatment, cancer in the elderly and quality of care for cancer patients. She is Deputy Editor of the Journal of the National Cancer Institute and Associate Editor of CA-A Journal for Clinicians. Dr. Ganz was elected to the Institute of Medicine in 2007, and received the American Cancer Society Medal of Honor in 2010. She served on the National Cancer Institute Board of Scientific Advisors from 2002-2007 and on the American Society of Clinical Oncology (ASCO) Board of Directors from 2003-2006. Dr. Ganz currently serves as Vice Chair of the Institute of Medicine National Cancer Policy Forum and chaired the 2013 Institute of Medicine consensus study whose report was entitled “Delivering High Quality Cancer Care: Charting a New Course for a System in Crisis.”
Co-director Julienne Bower, Ph.D., is professor of Psychology and Psychiatry and Biobehavioral Sciences, and Research Scientist of the Cousins Center for Psychoneuroimmunology at the UCLA Semel Institute for Neuroscience. Bower’s research is focused on understanding the biobehavioral mechanisms underlying fatigue and other behavioral disturbances in cancer patients and survivors, and has done pioneering work on inflammation and cancer-related fatigue. She is also actively involved in designing and conducting interventions for cancer patients and survivors, including trials of mind-body therapies. In July 2016, Bower was appointed to the George F. Solomon Professorship of Psychobiology. In collaboration with the Norman Cousins Center for Psychoneuroimmunology at UCLA, she leads the effort to develop innovative programs in evidence-based behavioral approaches to prevent disease, promote healing and enhance overall well-being in patients and survivors of cancer.
The following list is for upcoming events and seminars of notable interest to the Patients and Survivors Program and its members. This calendar is updated automatically.
For a list of all upcoming JCCC events (including other research programs, patients and survivors, and the UCLA Jonsson Cancer Center Foundation), please visit the Events Calendar.
Insights into Cancer: Sarcomas
Treating rare cancers with targeted therapy
- Date: August 08, 2017 7:00 PM - 9:00 PM
- Location: Ronald Reagan UCLA Medical Center Auditorium, B Level Room B130
757 Westwood Plaza
Los Angeles, California 90095
Once a month, the Simms/Mann–UCLA Center for Integrative Oncology presents Insights Into Cancer, a free public lecture series for cancer patients, their families and the community. Each lecture features a leading professional who provides up-to-date information, practical advice and answers to cancer-related questions.
August 8, 2017
Sarcomas: Treating Rare Cancers with Targeted Therapy
Dr. Arun Singh, assistant professor and Co-Director of the Medical Oncology Sarcoma Program, reviews the diagnosis, treatment and follow-up care of patients diagnosed with sarcomas – a spectrum of rare diseases. He discusses the importance of the multidisciplinary approach in caring for patients with these malignancies. He presents the evolving biologic understanding of sarcomas and how these new insights are leading to the development of the next generation of therapies for these patients.
6:45 – 7:00: Arrival & Refreshments
7:00 – 7:15: Anne Coscarelli, Ph.D, Introduction to Center
7:15 – 7:20: Anne Coscarelli, Ph.D., Speaker Introduction
7:20 – 8:55: Speaker Presentation, Q&A
8:55 – 9:00: Closing
Arun Singh, M.D., is an assistant professor in the Department of Medicine, Division of Hematology/Oncology at the David Geffen School of Medicine UCLA. Dr. Singh is a Hematologist and Medical Oncologist whose practice focuses on the treatment of bone and soft tissue sarcomas. Dr. Singh’s research focus is on developing novel therapies for patients with sarcomas. In the preclinical setting, he works on elucidating the mechanisms contributing to the promotion of growth in cancer cells and optimizing the use of targeted therapy in specific sarcoma subtypes. The insights gained from these efforts are then translated into the clinic in the form of new drugs in early stage Phase I and II clinical trials for sarcomas where there is an unmet clinical need.
Insights Into Cancer lectures are held in the Ronald Reagan UCLA Medical Center Auditorium, B Level, Room B130, 757 Westwood Plaza, Los Angeles, CA 90095.
UCLA parking is $12 and is wheelchair accessible. Attendees can park in the medical plaza, or take advantage of the valet parking at the front of Ronald Reagan UCLA Medical Center.